Clinical Trial Update: A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure [Phase 1]

View source ↗

Summary

The Phase 1 study of ularitide for acute decompensated heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Heart Failure

Drugs mentioned

• Ularitide (ularitide)

Snippet

Sponsor: Facet Biotech | Conditions: Heart Failure, Congestive | Phase 1 | Status: WITHDRAWN